So why are you so paranoid to come clean and answer he question? You are SO conflicted. You pretend to have a $1,000 price target, yet you also claim you don't trust the CEO, his motive, etc.
Just admit you lost your #$%$ shorting AEGR and are just a hate-filled bitter person with NO position in the stock whatsoever.
You still have no position in this stock at all right?
You are just here out of hatred and bitterness of your short position gone horribly horribly wrong.
But since you won't take responsibility for your own lack of due diligence or research, like a good Democrat, you want a law made - or where is the SEC? Since that won't work, you just want to badger everybody else.
Why do you lie? You lied & said they were bailing, but at is a complete and total lie and is easily refuted by the stats on Yahoo that clearly show institutions are BUYING not bailing.
Why lie if you are right?
OR they keep accelerating sales and the valuation continues to grow.
Not even a little bit. They are executing a sound business strategy, continuing to grow revenues rapidly, and are broadening out their customer base substantially. It doesn't get much better than this.
No surprise really, nobody else agrees with him so he has to pretend there are other people on his side.
Since there is no reason for the 15% decline, then by Censored's reasoning, it can only be market manipulation. Otherwise, if he maintains that it never should have gone that high ($97) then he has to allow for the counter-argument that it should never be this low.
Why Arthur, you got yourself a new id. Full of the same sad lonely bitterness, but a new name to pretend under.
ISIS keeps failing and everybody know it. They aren't a threat to anybody but themselves.
So ... why are you here then? You won't short the stock, yet don't own any long because you think it is already overpriced. You are here for the scenery?
Do you always frequent boards that you have no vested interest in whatsoever?
Methinks you lie.
The numbers become more compelling each and every day.
If we just look at the numbers:
Based on 15,000 worldwide patients at $300,000 per year for each patient
That yields $4.5B/year in revenues
Divide that $4.5B by the 28M shares outstanding and we get a revenue per share value of $160.00/share
We can calculate the earnings based valuation model of:
at a PE of 10 = $1,600.00/share
at a PE of 20 = $3,150.00/share
at a PE of 40 = $6,300.00/share
Makes us realize that $85/share is SO incredibly cheap.
Hopefully we can get a good pullback across the board in stocks so we can buy on an artificial dip. Then when earnings are announced we can plus-up 25% or more.
Arthur, do your meds help you keep all your imaginary friends (Censored, Arthur1, Jetmanbash, AdamWang) straight?
Real numbers, real patients, real revenue, real results, and most importantly, real ROI .
More of that "Research" VooDoo and all that nonsense about checking facts and references. Censored-Sam-Arthur-Adam can't fathom any of those ideas.